Table 3.

Odds Ratios for Impaired Awareness of Hypoglycemia Assessed by Gold-TW Criteria, According to Duration of Insulin and Sulfonylurea Use

Drug and Duration of UseModel 1 Crude OR (95% CI)Model 2a Adjusted OR (95% CI)Model 3b Adjusted OR (95% CI)Model 4c Adjusted OR (95% CI)
Duration of insulin use
No use1.001.001.001.00
<1 year0.72 (0.46-1.13)0.72 (0.45-1.15)0.72 (0.42-1.23)0.73 (0.42-1.26)
1-2 years0.43 (0.28-0.64)0.43 (0.28-0.65)0.55 (0.35-0.88)0.55 (0.35-0.88)
3-4 years0.38 (0.24-0.60)0.37 (0.23-0.59)0.52 (0.31-0.87)0.54 (0.32-0.92)
≥5 years0.25 (0.17-0.35)0.23 (0.16-0.33)0.32 (0.21-0.48)0.33 (0.22-0.49)
Duration of sulfonylurea use
No use1.001.001.001.00
<1 year1.46 (0.63-3.38)1.46 (0.62-3.46)0.43 (0.17-1.08)0.42 (0.17-1.03)
1-2 years2.68 (1.54-4.68)2.92 (1.64-5.21)1.11 (0.57-2.15)1.09 (0.56-2.12)
3-4 years1.89 (1.10-3.25)1.91 (1.10-3.29)1.11 (0.58-2.12)1.06 (0.54-2.09)
≥5 years3.84 (2.75-5.38)3.91 (2.78-5.52)3.56 (2.45-5.19)3.50 (2.39-5.13)
  • Gold-TW = Chinese version of Gold questionnaire; OR = odds ratio.

  • Note: Multiple logistic regression models with sequential adjustment for potential confounders. The “no use” groups are the reference groups.

  • a Adjusted for sociodemographics: age, sex, highest education level, marital status, living area, occupation, living arrangement.

  • b Adjusted for sociodemographics and disease history and medical care: diabetes duration, outpatient visit for diabetes care in past year, blood glucose test in past 3 months, urine microalbumin test in past year, retina examination in past year, foot examination in past year.

  • c Adjusted for sociodemographics, disease history and medical care, and health status: perceived health, limited daily activities for ≥6 months.